TUSC1 Blocking Peptide (C-Term)
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q2TAM9 |
---|
Gene ID | 286319 |
---|---|
Other Names | Tumor suppressor candidate gene 1 protein, TSG-9, TSG9, TUSC1 |
Target/Specificity | The synthetic peptide sequence is selected from aa 128-141 of HUMAN TUSC1 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | TUSC1 |
---|---|
Tissue Location | Widely expressed at low level. Expressed at higher level in testis, weakly expressed in muscle, colon, lung and spleen Not detected in 3 non small cell lung carcinoma (NSCLC) cell lines with homozygous deletion of the 9p region, while it is down-regulated in 3 other tumor cell lines. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
References
Shan Z.,et al.Oncogene 23:6612-6620(2004).
Humphray S.J.,et al.Nature 429:369-374(2004).
Olsen J.V.,et al.Cell 127:635-648(2006).
Burkard T.R.,et al.BMC Syst. Biol. 5:17-17(2011).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.